[144] Sight Sciences, Inc. SEC Filing

Rhea-AI Filing Summary

Sight Sciences, Inc. filing a Form 144 reports a proposed sale of 591 common shares with an aggregate market value of $1,992.32. The seller acquired these shares on 09/30/2025 through restricted stock vesting and the payment type is listed as compensation. The proposed approximate sale date is 10/06/2025 on NASDAQ. The filing shows 52,367,359 shares outstanding for the issuer and indicates no sales by the seller in the past three months. The filer attests there is no undisclosed material adverse information and includes the standard signature and legal notice language.

Positive

• Clear disclosure of share count (591) and aggregate value ($1,992.32)
• Acquisition and payment details provided (vested restricted stock on 09/30/2025; payment = compensation)
• Broker named for execution (Fidelity Brokerage Services LLC) enabling traceability of transaction

Negative

• No material negatives evident; transaction size is immaterial relative to 52,367,359 shares outstanding

Insights

Securities Compliance Analyst

Routine insider sale notice tied to equity compensation.

The filing documents a small, specified offer to sell 591 shares that vested as restricted stock on 09/30/2025, with proceeds shown as $1,992.32. This is a standard Rule 144 notice indicating the holder intends to sell restricted or control securities through a broker.

The main compliance dependencies are the continued availability of Rule 144 resale conditions (public information, holding period, volume limits) and execution on the indicated date 10/06/2025. Watch confirmations of sale execution and any subsequent Form 4 or Form 5 filings that would report the actual disposition within the statutory timelines.

Equity Capital Markets Specialist

Transaction is immaterial to market capitalization but relevant for insider trading records.

The proposed sale size is de minimis versus the issuer's 52,367,359 outstanding shares, so it’s unlikely to impact market price or liquidity. The use of a major broker (Fidelity Brokerage Services LLC) signals a normal brokerage execution.

Investors or compliance teams should note the acquisition date and nature (09/30/2025, restricted stock vesting) for vesting and tax timelines and confirm whether proceeds are treated as compensation on tax reporting for the recipient.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	591	1992.32	52367359	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Restricted Stock Vesting	Issuer			591	09/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by Sight Sciences (SGHT) report?

It reports a proposed sale of 591 common shares with an aggregate market value of $1,992.32, expected to be sold on 10/06/2025 on NASDAQ.

How were the shares acquired according to the filing for SGHT?

The shares were acquired on 09/30/2025 via restricted stock vesting and the filing lists payment as compensation.

Does the Form 144 show prior sales by the seller in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What broker is handling the proposed sale in the SGHT Form 144?

The named broker is Fidelity Brokerage Services LLC located in Smithfield, RI.

How large is the issuer's share base reported in the filing?

The filing indicates 52,367,359 shares outstanding for the issuer.